Hemorrhagic disease of the newborn despite vitamin K prophylaxis at birth

Pediatric Blood and Cancer

Volumn 50, Issue 5, 2008, Pages 1075-1077

  Flood, Veronica H ^a,b   Galderisi, Faith C ^a   Lowas, Stefanie R ^a   Kendrick, Angela ^a   Boshkov, Lynn K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Bleeding disorders; Esp. in newborns; Intracranial hemorrhage; Vitamin K

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP;

ARTICLE; BIRTH; BRAIN HEMORRHAGE; BREAST FEEDING; CASE REPORT; CLINICAL FEATURE; CRANIECTOMY; DIARRHEA; HUMAN; INFANT; MALE; MORBIDITY; NEONATAL HEMORRHAGE; NEWBORN; PRIORITY JOURNAL; SKIN BRUISING;

FACTOR VIIA; HEMORRHAGIC DISEASE OF NEWBORN; HUMANS; INFANT; INFANT, NEWBORN; MALE; RECOMBINANT PROTEINS; VITAMIN K; VITAMIN K DEFICIENCY; VITAMINS;

EID: 41849099695     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21383     Document Type: Article

References (14)

1. Sutor AH. Vitamin K deficiency bleeding in infants and children. Semin Thromb Hemost 1995;21:317-329.
2. Suttie JW. Synthesis of vitamin K-dependent proteins. FASEB J 1993;7:445-452.
3. Shapiro AD, Jacobson LJ, Armon ME, et al. Vitamin K deficiency in the newborn infant: Prevalence and perinatal risk factors. J Pediatr 1986;109:675-680.
4. Lane PA, Hathaway WE. Vitamin K in infancy. J Pediatr 1985;106:351-359.
5. American Academy of Pediatrics Committee on Fetus and Newborn. Controversies concerning vitamin K and the newborn. American Academy of Pediatrics Committee on Fetus and Newborn. Pediatrics 2003;112:191-192.
6. Lankiewicz MW, Hays J, Friedman KD, et al. Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 2006;4:967-970.
7. Schulman S, Bijsterveld NR. Anticoagulants and their reversal. Transfus Med Rev 2007;21:37-48.
8. Lisman T, De Groot PG. Mechanism of action of recombinant factor VIIa. J Thromb Haemost 2003;1:1138-1139.
9. Wong WY, Huang WC, Miller R, et al. Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency. Haemophilia 2000;6:50-54.
10. Hunseler C, Kribs A, Eifinger F, et al. Recombinant activated factor seven in acute life-threatening bleeding in neonates: Report on three cases and review of literature. J Perinatol 2006;26:706-713.
11. Berntorp E. Recombinant FVIIa in the treatment of warfarin bleeding. Semin Thromb Hemost 2000;26:433-435.
12. Zipursky A. Prevention of vitamin K deficiency in newborns. Br J Haematol 1999;106:256.
13. Brenner B, Sanchez-Vega B, Wu SM, et al. A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 1998;92:4554-4559.
14. Ito K, Goto K, Sugiura T, et al. Polymorphisms of the factor VII gene associated with the low activities of vitamin K-dependent coagulation factors in one-month-old infants. Tohoku J Exp Med 2007;211:1-8.